$15.56
+2.35 (+17.79%)
INM News3 articles
Mentari's $200M Private Placement Boosts InMed Merger Funding
InMed Pharmaceuticals (INM) shares rose 21% after Mentari Therapeutics revealed a $200M private placement, boosting total merger financing to $490M.
InMed Stock Retreats After 135% Merger Rally; Deal Dilution Weighs
InMed Pharmaceuticals shares fell 14.4% in pre-market trading Wednesday, giving back some of Tuesday's 135% surge on news of an all-stock merger with Mentari Therapeutics and a $290 million private placement.
InMed Shares Surge 109% on $290M Migraine Deal with Mentari
InMed Pharmaceuticals shares surged 108.6% to $1.42 after announcing an all-stock merger with Mentari Therapeutics, backed by a $290 million private placement, pivoting to migraine prevention.